we are Talking about the vaccine, developed at research centre of epidemiology and Microbiology named Gamalei, Ministry of health of Ukraine (NICAM). As previously stated the Centre’s Director, academician Alexander Ginzburg, the first tests on the volunteer staff working on the vaccine were held in may and is now conducting a large-scale clinical studies in cooperation with the Ministry of defense.
“the anticipated period of the provision of the registration dossier and registration – August. Accordingly, industrial production, which they assume is September,” – said Golikova today at the briefing dedicated to the situation with COVID-19 in Russia.
in Parallel with the scientists of the Centre Gamalei on a few versions of the vaccine are also in the state research center “Vector” of Rospotrebnadzor and the St. Petersburg Institute of vaccines and serums FMBA Russia.
the “Vector” also start clinical studies – they will last until September and the registration scheduled to be held in September. Immediately after that it is expected to launch vaccine production. On Biocode, which collaborates with scientists “Vector”, stated that an experimental batch, necessary for testing were produced in the given time frame. And in August, the production will be ready to scale the vaccine. According to the head of Biocad Dmitry Morozov, the company is ready to produce 5 million doses of vaccine annually.
